Joe Duarte

Dr. Joe Duarte has been a professional investor and independent analyst since 1990.  He is a former Registered Investment Advisor and author of the Bestselling "Options Trading for Dummies," now in its 4th edition and several other books including "Market Timing for Dummies" and "Successful Biotech Investing". Although Joe's favorite areas of the market are technology and healthcare, he is a versatile investor who enjoys finding that hidden gem stock before the crowd, no matter what the sector. He is an original CNBC Market Maven, and is visible regularly on Stockcharts.TV. He has published articles on Marketwatch.com and has been widely quoted in the major media including The Wall Street Journal and Barron’s magazine.  

Analyst Articles

Our foray into UBIO, the leveraged long biotech ETF,  got a rough start.  But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More

Our foray into UBIO, the leveraged long biotech ETF,  got a rough start.  But those investors who have owned BIS, the inverse leveraged biotech ETF, especially simultaneously with UBIO have fared better overall since BIS shares have risen during the period in which UBIO has fallen. We still think that biotech… Read More

The main questions for biotech investors are whether there is a correlation between the price of oil and if there is such a correlation, what is it telling us at the current period and the potential for the price action in the biotech sector? Read More

The main questions for biotech investors are whether there is a correlation between the price of oil and if there is such a correlation, what is it telling us at the current period and the potential for the price action in the biotech sector? Read More